eli lilly glp 1 stock analysis Shows Why the GLP-1 Trade Is Still About Volume, Not Pricing Eli Lilly Q1 2026 Earnings

Altimmune just made a big move in the world of GLP-1 research, but this time, its not about obesity.The company announced yesterday that it has officially begun enrolling participants in a Phase 2 trial of pemvidutide, its GLP-1 and glucagon dual receptor agonist, to evaluate the drug in people with Alcohol Use Disorder, or AUD

We deliver your prescriptions right to your door and our pharmacists are available 24/7

Compounding pharmacies arent the only makers of off-brand versions of Novo Nordisks Wegovy and Eli Lillys Zepbound

Maria Kalaitzandonakes, Brenna Ellison, Trey Malone, and Jonathan Coppess - Maria Kalaitzandonakes -

Indias drug regulator steps up action against unauthorised sale and promotion of GLP-1 weight-loss drugs, warning of health risks and tightening inspections across pharmacies and online platforms.

*Productisshipped with ice, but the ice may be warm upon arrival